Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries-Reference-Cited by-同舟云学术

Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries

Published:2021-07-05 Issue:6 Volume:35 Page:1171-1182
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drugs Ther

Author:

Bianco Matteo,Careggio Alessandro,Biolè Carlo Alberto,Quadri Giorgio,Quiros Alicia,Raposeiras-Roubin Sergio,Abu-Assi Emad,Kinnaird Tim,Ariza-Solè Albert,Liebetrau Christoph,Manzano-Fernàndez Sergio,Boccuzzi Giacomo,Henriques Jose P. S.,Spirito Amanda,Templin Christian,Wilton Stephen B.,Velicki Lazar,Correia Luis,Rognoni Andrea,Ugo Fabrizio,Nunez-Gil Ivàn,Fujii Toshiharu,Durante Alessandro,Song Xiantao,Kawaji Tetsuma,Alexopoulos Dimitrios,Huczek Zenon,Gonzàlez Juanatey Josè Ramòn,Nie Shao-Ping,Kawashiri Masa-Aki,Morbiducci Umberto,Dominguez-Rodriguez Alberto,Destefanis Paola,Luciano Alessia,De Ferrari Gaetano Maria,Varbella Ferdinando,Montagna Laura,D’Ascenzo Fabrizio,Cerrato Enrico

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10557-021-07213-y.pdf

Reference29 articles.

1. Valgimigli M, Bueno H, Byrne RA, Collet J-P, Costa F, Jeppsson A, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39(3):213–60.

2. Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2016;152(5):1243–75.

3. Gravinese C, Bianco M, Cerrato E, Destefanis P, Luciano A, Bernardi A, et al. Is aspirin still the cornerstone of antiplatelet therapy in patients with coronary artery disease? An historical and practical narrative review. Hosp Pract Res. 2017;2(4):94–101.

4. De Luca L, Leonardi S, Cavallini C, Lucci D, Musumeci G, Caporale R, et al. Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: the EYESHOT study. Eur Heart J Acute Cardiovasc Care. 2015;4(5):441–52.

5. Tegn N, Abdelnoor M, Aaberge L, Endresen K, Smith P, Aakhus S, et al. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (after eighty study): an open-label randomised controlled trial. Lancet. 2016;387(10023):1057–65.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Strategies to Guide the Antiplatelet Therapy in Acute Coronary Syndromes;International Journal of Molecular Sciences;2024-04-03

2. PAR4 Antagonism in Patients With Coronary Artery Disease Receiving Antiplatelet Therapies;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-04

3. Association of dual antiplatelet therapy with adverse outcomes in octogenarian patients without atrial fibrillation who underwent percutaneous coronary intervention;Turkish Journal of Geriatrics;2023-06

4. Utilization Trends In Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor and Cost Among Medicare Beneficiaries;Current Problems in Cardiology;2023-05

5. Acute coronary syndrome in very elderly patients—a real-world experience;Heart and Vessels;2023-03-28